With Triton, clinicians have a more precise, objective metric to accurately estimate blood loss and make more informed treatment decisions that improve patient outcomes, all while creating value for hospitals.
LOS ALTOS, Calif. (PRWEB) July 10, 2018
Gauss Surgical, Inc. announced today a partnership with Georgia Hospital Health Services (GHHS), the shared services subsidiary of the Georgia Hospital Association (GHA), aimed at transforming obstetric patient care throughout Georgia, which has had the highest rates of maternal mortality within the United States. Gauss Surgical is the company behind Triton, the world’s first and only mobile platform for real-time blood loss monitoring.
An inability to accurately measure blood loss during surgery and labor & delivery can lead to complications and even patient death. For cesarean deliveries in particular, current approaches to measuring blood loss are unreliable. Inaccurate blood loss assessment can either unsafely delay the diagnosis of post-partum hemorrhage (PPH), or result in overestimation of blood loss, leading to unnecessary transfusions, costly challenges for both the hospital and the patient.
GHA hopes to help address these challenges to obstetric care in Georgia by promoting the use of Triton to member hospitals. Triton is a real-time blood loss monitoring platform that provides an objective metric for blood loss to assist in early recognition of postpartum hemorrhage and support clinical decision-making related to transfusion appropriateness. Triton utilizes artificial intelligence capabilities such as computer vision and machine learning to accurately and objectively estimate blood loss, all delivered through an app that runs on the iPad.
Triton consists of two components, Triton OR, which captures blood loss collected by surgical sponges and suction canisters while integrating into the OR workflow, and Triton L&D, which streamlines quantification of blood loss (QBL) during vaginal deliveries and in postpartum recovery.
The clinical outcome improvements demonstrated by the use of Triton support its role in the delivery of cost-effective care. These include a reduction in units of transfused blood, shortened lengths of stay and limited ICU days, all of which translate into economic savings for the hospital.
“Unrecognized blood loss is a significant contributor to the issue of post-partum hemorrhage related morbidity and mortality. With Triton, clinicians have a more precise, objective metric to accurately estimate blood loss and make more informed treatment decisions that improve patient outcomes, all while creating value for hospitals,” said Siddarth Satish, founder and chief executive officer of Gauss Surgical. “We’re proud to partner with GHHS in delivering a comprehensive blood loss monitoring solution for obstetrics departments throughout Georgia.”
GHHS strives to locate companies or programs that offer a strategic benefit for GHA member hospitals. GHA is a non-profit trade association made up of member health systems, hospitals, and individuals in administrative and decision‐making positions within those institutions. Founded in 1929, GHA serves 170 hospitals in Georgia. Its purpose is to promote the health and welfare of the public through the development of better hospital care for all of Georgia’s citizens. GHA members are committed to improving institutional healthcare services and, in turn, patient care.
About Gauss Surgical
Gauss Surgical is a medical technology company based in Los Altos, California that develops novel FDA-grade mobile applications for patient monitoring, with a focus on computer vision and machine learning applications. Gauss’s flagship product, Triton, is the world’s first real-time monitor for surgical blood loss. For more information, go to http://www.gausssurgical.com.